专题:Metabolism, Diabetes, and Cancer

This cluster of papers explores the role of AMP-activated protein kinase (AMPK) in regulating cellular metabolism, including its involvement in glucose and lipid metabolism, insulin signaling, mitochondrial homeostasis, and the potential impact on cancer risk. The cluster also delves into the mechanisms of action of metformin, a drug known to activate AMPK and its effects on cellular energy balance and gene expression regulation.
最新文献
Insulin Resistance at the Crossroads of Metabolic Inflammation, Cardiovascular Disease, Organ Failure and Cancer

article Full Text OpenAlex

Antidiabetic Agents as Antioxidant and Anti-Inflammatory Therapies in Neurological and Cardiovascular Diseases

article Full Text OpenAlex

Metabolic rebound after GLP-1 receptor agonist discontinuation: a systematic review and meta-analysis

review Full Text OpenAlex

Glucose starvation mimetic aldometanib removes immune barriers permitting mice with hepatocellular carcinoma to live to normal ages

article Full Text OpenAlex

New‐onset prediabetes/diabetes worsens overall survival in patients with cancer: A real‐world retrospective cohort study

article Full Text OpenAlex

AMPK/SIRT1/PGC‐1α Signaling Pathway: Molecular Mechanisms and Targeted Strategies From Energy Homeostasis Regulation to Disease Therapy

review Full Text OpenAlex

From weight loss to muscle loss: rhabdomyolysis linked to semaglutide

article Full Text OpenAlex

High-fat Diet-associated Digestive Cancers: Mechanisms, Natural Product-based Therapies, and Drug Development

article Full Text OpenAlex

Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial

article Full Text OpenAlex

Obesity Paradox in Cancer: A Complex Interplay Between Risk and Therapeutic Outcomes

article Full Text OpenAlex

近5年高被引文献
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

article Full Text OpenAlex 2214 FWCI451.0384

The hallmarks of cancer metabolism: Still emerging

review Full Text OpenAlex 1273 FWCI116.384

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes

article Full Text OpenAlex 1244 FWCI457.7448

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

review Full Text OpenAlex 919 FWCI118.1723

Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial

article Full Text OpenAlex 867 FWCI176.2538

New insights into activation and function of the AMPK

review Full Text OpenAlex 854 FWCI68.441

Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension

article Full Text OpenAlex 793 FWCI101.2906

Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease

review Full Text OpenAlex 751 FWCI117.6488

PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?

review Full Text OpenAlex 731 FWCI62.1954

Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

article Full Text OpenAlex 706 FWCI90.1291